Skip to content
Login

EPLAW Patent Blog: latest European patent law developments

With thanks to our sponsors

https://www.coupry.nl/
https://www.brinkhof.com/
https://www.hoyngrokhmonegier.com/
https://www.pinsentmasons.com/
https://www.arnold-siedsma.com/
https://www.wr.no/
https://www.vondst.com/
https://www.eplaw.org/about/dr-j-alingh-prins-fund/
https://www.roschier.com/
https://www.linklaters.com/
https://www.gassauer.com/
https://www.lenzstaehelin.com/
https://www.stibbe.com/
https://www.bardehle.com/
https://simontbraun.eu/
https://www.simmons-simmons.com/
https://powellgilbert.com/
https://roa.pl/
https://www.arnold-ruess.com/en
https://www.freshfields.com/
https://www.danubia.com/
https://www.bristows.com/
https://www.barentskrans.nl/
https://www.danubia.com/
https://www.twobirds.com/
https://www.plesner.com/
https://www.lagro.com/
10 September 2024
UPC – Meril v. Edwards Lifesciences / Procedural Order Appeal
05 September 2024
NL – Geberit v. Voordelingdesignsanitair.nl
03 September 2024
NL – HE Licenties v. Orchid Gardens
02 September 2024
EPO – Decision of the President of the EPO on the signing and filing of authorisations (also applicable to European patents with unitary effect)
30 August 2024
NEWS – The second joint EPLAW/EPO webinar: UPC – One year in practice – from the litigator’s perspective
08 August 2024
UK – Samsung Bioepis v. Janssen Biotech / ustekinumab
06 August 2024
UPC – Meril Life Sciences c.s. v. Edwards Lifesciences Corporation: Auxiliary request proves to be a life saver
19 July 2024
UPC – Sanofi v. Amgen – on claim interpretation, priority and inventive step
18 July 2024
NL – Stichting Farma ter Verantwoording v. AbbVie / mass damages claim re excessive pricing Humira
16 July 2024
UPC – Sanofi and Regeneron v. Amgen / First revocation judgments
12 July 2024
UK – Moderna v. Pfizer and BioNTech / Pledge
08 July 2024
UK – Moderna v. Pfizer & BioNTech

EPLAW Patent Blog

Get the latest European patent law developments

BLOG